Clarivate PLC

More Details of Clarivate PLC Company

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.

Company Info

Company codeCLVT

Company nameClarivate PLC

IPO dateOct 29, 2018

Founded at2019

CEOMr. Matitiahu Shem (Matti) Tov

Number of employees12000

Security typeOrdinary Share

Fiscal year-endOct 29

Address70 St. Mary Axe

CityLONDON

Stock exchangeNYSE Consolidated

CountryUnited Kingdom

Postal codeEC3A 8BE

Phone442074334000

Websitehttps://clarivate.com/

Company codeCLVT

IPO dateOct 29, 2018

Founded at2019

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Bar Veinstein

President - Academia and Government

729.15K

+150.40%

Mr. Jonathan Mark Collins

Chief Financial Officer, Executive Vice President

488.98K

+10.04%

Mr. Henry Levy

President - Life Sciences and Health care

451.59K

+93.78%

Dr. Saurabh Saha, M.D., Ph.D.

Independent Director

82.02K

+245.46%

Dr. Wendell E. Pritchett

Independent Director

71.83K

+46.67%

Ms. Valeria Alberola

Independent Director

57.73K

--

Mr. Michael J. Angelakis

Independent Director

56.09K

--

Mr. Jane Okun Bomba, CPA

Independent Director

--

Ms. Suzanne Heywood

Independent Director

--

Mr. Usama N. Cortas

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Bar Veinstein

President - Academia and Government

729.15K

+150.40%

Mr. Jonathan Mark Collins

Chief Financial Officer, Executive Vice President

488.98K

+10.04%

Mr. Henry Levy

President - Life Sciences and Health care

451.59K

+93.78%

Dr. Saurabh Saha, M.D., Ph.D.

Independent Director

82.02K

+245.46%

Dr. Wendell E. Pritchett

Independent Director

71.83K

+46.67%

Ms. Valeria Alberola

Independent Director

57.73K

--

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Subscription revenues

1.63B

63.63%

Transactional revenues

500.10M

19.56%

Re-occurring revenues

429.80M

16.81%

By RegionUSD

Name

Revenue

Proportion

Americas

1.38B

54.03%

Europe/ Middle East /Africa

667.80M

26.12%

Asia Pacific

507.50M

19.85%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Subscription revenues

1.63B

63.63%

Transactional revenues

500.10M

19.56%

Re-occurring revenues

429.80M

16.81%

Shareholder

Update time: Sun, Feb 23

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

Leonard Green & Partners, L.P.

17.08%

Clarkston Capital Partners, LLC

10.35%

Giovanni Agnelli B V

9.85%

Impactive Capital LP

6.30%

Onex Corporation

6.14%

Other

50.28%

Shareholder Statistics

Shareholder

Proportion

Leonard Green & Partners, L.P.

17.08%

Clarkston Capital Partners, LLC

10.35%

Giovanni Agnelli B V

9.85%

Impactive Capital LP

6.30%

Onex Corporation

6.14%

Other

50.28%

Type

Shareholder

Proportion

Investment Advisor

30.25%

Private Equity

30.20%

Investment Advisor/Hedge Fund

18.94%

Hedge Fund

11.75%

Holding Company

9.77%

Corporation

5.53%

Individual Investor

1.00%

Research Firm

0.99%

Bank and Trust

0.94%

Institutional Shareholding

Update time: Sat, Feb 22

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

674

765.26M

112.02%

-141.15M

2024Q4

712

766.77M

110.84%

-166.20M

2024Q3

726

765.53M

108.25%

-158.23M

2024Q2

741

760.08M

105.78%

-120.39M

2024Q1

752

730.14M

108.67%

-137.39M

2023Q4

783

725.50M

108.90%

-179.38M

2023Q3

791

741.16M

111.25%

-79.71M

2023Q2

796

712.25M

105.35%

-100.17M

2023Q1

777

702.68M

104.01%

-43.46M

2022Q4

788

663.31M

98.18%

-69.01M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

Leonard Green & Partners, L.P.

116.67M

16.93%

--

Dec 31, 2024

Clarkston Capital Partners, LLC

70.73M

10.27%

-1.48M

-2.04%

Dec 31, 2024

Giovanni Agnelli B V

67.29M

9.77%

--

Dec 31, 2024

Impactive Capital LP

43.03M

6.25%

+3.40M

+8.58%

Dec 31, 2024

Onex Corporation

42.86M

6.22%

--

Mar 15, 2024

Selige Co-Investor Pooling SCSp

38.09M

5.53%

--

Mar 15, 2024

The Baupost Group, L.L.C.

36.28M

5.27%

-2.65M

-6.81%

Dec 31, 2024

T. Rowe Price Associates, Inc.

27.41M

3.98%

+9.67M

+54.48%

Dec 31, 2024

Partners Group AG

25.58M

3.71%

--

Dec 31, 2024

Cambridge Information Group, Inc.

23.61M

3.43%

--

Mar 15, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

AGF US Market Neutral Anti-Beta Fund

0.48%

WisdomTree US MidCap Fund

0.17%

John Hancock Multifactor Small Cap ETF

0.17%

Avantis US Small Cap Value ETF

0.15%

JPMorgan US Value Factor ETF

0.15%

T Rowe Price Small-Mid Cap ETF

0.14%

Nuveen ESG Small-Cap ETF

0.14%

Strive Small-Cap ETF

0.1%

BNY Mellon US Small Cap Core Equity ETF

0.08%

iShares ESG Aware MSCI USA Small-Cap ETF

0.07%

AGF US Market Neutral Anti-Beta Fund

Proportion0.48%

WisdomTree US MidCap Fund

Proportion0.17%

John Hancock Multifactor Small Cap ETF

Proportion0.17%

Avantis US Small Cap Value ETF

Proportion0.15%

JPMorgan US Value Factor ETF

Proportion0.15%

T Rowe Price Small-Mid Cap ETF

Proportion0.14%

Nuveen ESG Small-Cap ETF

Proportion0.14%

Strive Small-Cap ETF

Proportion0.1%

BNY Mellon US Small Cap Core Equity ETF

Proportion0.08%

iShares ESG Aware MSCI USA Small-Cap ETF

Proportion0.07%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

4.335USD

Clarivate PLC

4.335

Overview

Company